Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.
Open Access
- 1 November 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (9) , 2354-2361
- https://doi.org/10.1172/jci119775
Abstract
The role of splanchnic glucose uptake (SGU) after oral glucose administration as a potential factor contributing to postprandial hyperglycemia in non-insulin-dependent diabetes mellitus (NIDDM) has not been established conclusively. Therefore, we investigated SGU in six patients with NIDDM and six weight-matched control subjects by means of the hepatic vein catheterization (HVC) technique. In a second part, we examined the applicability of the recently developed OG-CLAMP technique in NIDDM by comparing SGU and first-pass SGU during HVC with SGU during the OG-CLAMP experiment. The OG-CLAMP method combines a euglycemic, hyperinsulinemic clamp and an oral glucose tolerance test (75 g) during steady state glucose infusion (GINF). During HVC, SGU equals the splanchnic fractional extraction times the total (oral and arterial) glucose load presented to the liver. For OG-CLAMP, SGU was calculated as first-pass SGU by subtracting the integrated decrease in GINF over 180 min from 75 g. Cumulative splanchnic glucose output after oral glucose correlated significantly between both methods and was increased significantly in NIDDM patients (73.1+/-5.1 g for HVC, 76.5+/-5.5 for OG-CLAMP) compared with nondiabetic patients (46.7+/-4.4 g for HVC, 57.5+/-1.9 for OG-CLAMP). Thus, in NIDDM patients, SGU (7.4+/-2.1 vs. 37.8+/-5.9% in nondiabetic patients, P < 0.001) and first-pass SGU (4.7+/-1.7 vs. 26.5+/-5.1% in nondiabetic patients, P < 0.01) were decreased significantly during HVC, as was SGU during OG-CLAMP (3.9+/-1.7 vs. 23.4+/-2.5% in nondiabetic patients, P < 0.0001). SGU measured during OG-CLAMP correlated significantly with SGU (r = 0.87, P < 0.05 for NIDDM patients; r = 0.94, P < 0.01 for nondiabetic patients) and first-pass SGU (r = 0.87, P < 0.05 for NIDDM patients; r = 0.84, P < 0.05 for nondiabetic patients) during HVC. In conclusion, (a) SGU after oral glucose administration is decreased in NIDDM as measured by both methods, and (b) SGU during the OG-CLAMP is well-correlated to SGU and first-pass SGU during HVC in NIDDM. The decrease in SGU in NIDDM might contribute to postprandial hyperglycemia in diabetic subjects.Keywords
This publication has 22 references indexed in Scilit:
- Contribution of Splanchnic and Peripheral Vascular Tissues to the Disposal of Angiotensin-II and to Regional Conversion Rates of Angiotensin-IJournal of Cardiovascular Pharmacology, 1991
- Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.1991
- The disposal of an oral glucose load in patients with non-insulin-dependent diabetesMetabolism, 1988
- In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.Journal of Clinical Investigation, 1986
- Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.Journal of Clinical Investigation, 1986
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985
- The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic manMetabolism, 1980
- Influence of Maturity-onset Diabetes on Splanchnic Glucose Balance After Oral Glucose IngestionDiabetes, 1978
- GLUCAGON ANTIBODIES AND AN IMMUNOASSAY FOR GLUCAGON*Journal of Clinical Investigation, 1961
- ABSORPTION OF GLUCOSE AND METHIONINE FROM THE HUMAN INTESTINE; THE INFLUENCE OF THE GLUCOSE CONCENTRATION IN THE BLOOD AND IN THE INTESTINAL LUMENJournal of Clinical Investigation, 1952